Syneget-LS

Syneget-LS 90mg/400mg Tablet

Ledipasvir

GETZ PHARMA PAKISTAN (PVT) LTD.

Drug Identity

Active Ingredient
Ledipasvir
Drug Class
Antivirals For Systemic Use
0

What is Syneget-LS?

Uses
Monjuvi is used to treat diffuse large B-cell lymphoma (DLBCL ) in combination with lenalidomide that is relapsed or refractory (r/r), or...

How to Take It

Dosage information not available for this product.

Safety Alerts

Before you receive Monjuvi, tell your healthcare provider about all of your medical conditions, including if you: have an active infection or have had one recently are pregnant or plan to become pregnant are breastfeeding or plan to breastfeed

Important Warnings

Decompensated cirrhosis, patients awaiting liver transplantation, Co-infection with HBV, renal impairment

Side Effects

Headachealopeciafatigueanxietyastheniaconstipationdecreased appetitedepressiondiarrhoeadizzinessdry mouthdyspneagastro-oesophageal refluxabdominal discomfortirritability

Drug Interactions

Femotidine
omeprazole
digoxin
carbamazepine
phenytoin
oxcarbazepine
rifabutin
rifampin

Pregnancy & Lactation

Pregnancy
Avoid
Lactation
Avoid

Price Intelligence

Rs 59,865.08
DRAP approved maximum price · per pack of 28 · approved 27 Jul, 2026
No retail price observed for this pack. Retailers may not exceed the approved maximum.
Prices across sources
DRAPper pack of 28Rs 59,865.08

Should you consider an alternative?

Other options containing Ledipasvir, and what they are not.

Identical active ingredient at the same strength. Cheapest per unit first.

Ordered by lowest price per unit where a pack size is known, then by price. Order is never affected by sponsorship. Not medical advice — confirm any change with your pharmacist or doctor.

For pharma professionalsCompany, market and opportunity intelligence

Company

Prices as of 30 July 2026 · DRAP ceiling as of 30 July 2026 · schema v3-SKU

For medicine intelligence and professional reference only. Not medical advice.